ID: ALA3675250

Max Phase: Preclinical

Molecular Formula: C18H24N4S2

Molecular Weight: 360.55

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CN(C)CCCN1CCSc2cc(/N=C(\N)c3cccs3)ccc21

Standard InChI:  InChI=1S/C18H24N4S2/c1-21(2)8-4-9-22-10-12-24-17-13-14(6-7-15(17)22)20-18(19)16-5-3-11-23-16/h3,5-7,11,13H,4,8-10,12H2,1-2H3,(H2,19,20)

Standard InChI Key:  AIXCRSGMKMJRRJ-UHFFFAOYSA-N

Associated Targets(Human)

Nitric-oxide synthase, endothelial 1452 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nitric-oxide synthase, brain 1786 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nitric oxide synthase, inducible 1636 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.55Molecular Weight (Monoisotopic): 360.1442AlogP: 3.65#Rotatable Bonds: 6
Polar Surface Area: 44.86Molecular Species: BASEHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.52CX LogP: 3.24CX LogD: -0.09
Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.63Np Likeness Score: -1.88

References

1.  (2013)  Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, 

Source

Source(1):